Fundraising FoxCorvia Medical
Tewksbury, US · 5 known investors
Find your way into Corvia Medical
Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
Founders & leadership
Board
PL
KG
GB
IY
GB
UG
ML
HT
DC
David CelermajerBoard director
Investors · 5
Accelmed Partnerslisted by Accelmed PartnersMiami
How we know: Accelmed Partners's portfolio page · board seat on SEC Form D · Not right? Tell us
Lumira Ventureslisted by Lumira VenturesToronto · $1M – $10M
How we know: Lumira Ventures's portfolio page · board seat on SEC Form D · Not right? Tell us
.png)
General CatalystreportedSan Francisco · $30M
How we know: funding news · Not right? Tell us
SV Health InvestorsinferredLondon · $1M – $20Mvia Paul LaViolette · board
How we know: board seat on SEC Form D · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5Mvia Mark Levin · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.1M disclosed across 3 of 4 rounds · 2014–2025
▶$8.9MraisedJun 2025 · 10 investors · BiotechnologyRule 506(b)
▶$8.9MraisedJun 2025 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul LaVioletteDirector
- Kevin GillisDirector
- Gerald BrunkDirector
- George J. FazioExecutive Officer, Director
- Dan B. CurtisExecutive Officer
- David CelermajerDirector
- Irit YanivDirector
- Offering amount
- $11.1M
- Amount sold
- $8.9M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedJan 2021 · 25 investors · BiotechnologyRule 506(b)
▶$6.3MraisedJan 2021 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul LaVioletteDirector
- Gerry BrunkDirector
- Hemant TanejaDirector
- Mark LevinDirector
- David S. CelermajerDirector
- George J. FazioExecutive Officer, Director
- Uri GeigerDirector
- Offering amount
- $13.1M
- Amount sold
- $6.3M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34MraisedSep 2015 · 9 investors · BiotechnologyRule 506(b)
▶$34MraisedSep 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David S. CelermajerDirector
- Daniel B. CurtisExecutive Officer
- Paul LaVioletteDirector
- Gerry BrunkDirector
- George J. FazioExecutive Officer, Director
- Uri GeigerDirector
- Mark LevinDirector
- Hemant TanejaDirector
- Offering amount
- $34M
- Amount sold
- $34M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Corvia Medical went on to found or lead other companies.
In the news
Frequently asked questions
- What does Corvia Medical do?
- Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
- Who are Corvia Medical's investors?
- Corvia Medical's investors include Accelmed Partners, Lumira Ventures, General Catalyst, SV Health Investors, Third Rock Ventures.
- How much funding has Corvia Medical raised?
- Corvia Medical has disclosed $49.1M raised across 3 of its 4 known rounds.
- Where is Corvia Medical headquartered?
- Corvia Medical is headquartered in Tewksbury, US.